2024 American Academy of Neurology Abstract Website

Disclosures for "A Case of Paraneoplastic Cerebellar Degeneration (PCD) in a Patient with Merkel Cell Carcinoma Treated with Nivolumab"

Dr. Dangcalan has nothing to disclose.
The institution of Dr. McGraw has received research support from Novartis. The institution of Dr. McGraw has received research support from F. Hoffmann - La Roche. The institution of Dr. McGraw has received research support from Genentech. The institution of Dr. McGraw has received research support from Neurona Therapeutics. The institution of Dr. McGraw has received research support from Instituto Grifols, S.A..